Literature DB >> 1695648

CD38 molecule: structural and biochemical analysis on human T lymphocytes, thymocytes, and plasma cells.

M Alessio1, S Roggero, A Funaro, L B De Monte, L Peruzzi, M Geuna, F Malavasi.   

Abstract

The structure of the CD38 molecule has been evaluated by one- and two-dimensional gel analysis and by enzymatic digestions. The source of the Ag was mainly membrane preparations obtained from MLC cells, from normal thymocytes, and from the plasmocytoma line LP-1. Membranes were solubilized in NP-40 and the extracts fractionated by immunoaffinity chromatography [using a specific anti-CD38 antibody (A10 mAb) covalently linked to Sepharose protein A]. The purified Ag migrated as a single chain of Mr = 45,000 not associated with beta 2-microglobulin. Two-dimensional IEF gel electrophoresis revealed five spots (isoelectric point (pI) range: 6.5 to 6.9). After neuraminidase treatment, the mobility of the five polypeptides shifted to a more basic pI. Endoglycosidase-H treatment reduced the Mr of CD38 by 20%, revealing a broader band centered at Mr = 36,000. Treatment of CD38 molecule with V8 Staphylococcus aureus protease yielded a single dominant band at Mr = 38,000 which was still reactive with A10 mAb. The CD38 molecular was trypsin-resistant in both denatured or native conditions. These results clearly show the glycoprotein nature of CD38 molecule, which includes 2 to 4 N-linked oligosaccharide chains containing sialic acid residues. Furthermore, the present data indicate that the CD38 molecule does not display an apparent biochemical polymorphism among the different CD38+ cells or lines.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1695648

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  32 in total

1.  A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable.

Authors:  K S Froebel; G M Raab; C D'Alessandro; M P Armitage; K M MacKenzie; M Struthers; J M Whitelaw; S Yang
Journal:  Clin Exp Immunol       Date:  2000-10       Impact factor: 4.330

2.  Generation of human monoclonal antibodies that confer protection against pertussis toxin.

Authors:  M Zaccolo; S Roggero; D Armellini; L Pegoraro; R Rappuoli; F Malavasi
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

3.  Identification and functional characterization of the hepatic stellate cell CD38 cell surface molecule.

Authors:  Sandra March; Mariona Graupera; María Rosa Sarrias; Francisco Lozano; Pilar Pizcueta; Jaume Bosch; Pablo Engel
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Identification of a major enzyme for the synthesis and hydrolysis of cyclic ADP-ribose in amphibian cells and evolutional conservation of the enzyme from human to invertebrate.

Authors:  Takayuki Ikeda; Shin Takasawa; Naoya Noguchi; Koji Nata; Akiyo Yamauchi; Iwao Takahashi; Takeo Yoshikawa; Akira Sugawara; Hideto Yonekura; Hiroshi Okamoto
Journal:  Mol Cell Biochem       Date:  2012-03-16       Impact factor: 3.396

Review 5.  Cancer stem cell marker glycosylation: Nature, function and significance.

Authors:  Brody W Mallard; Joe Tiralongo
Journal:  Glycoconj J       Date:  2017-06-17       Impact factor: 2.916

6.  ImmunoPET imaging of CD38 expression in hepatocellular carcinoma using 64Cu-labeled daratumumab.

Authors:  Shiyong Li; Christopher G England; Emily B Ehlerding; Christopher J Kutyreff; Jonathan W Engle; Dawei Jiang; Weibo Cai
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

7.  Channelling of substrate promiscuity of the skeletal-muscle ADP-ribosyl cyclase isoform.

Authors:  Ingrid Bacher; Andreas Zidar; Martin Kratzel; Martin Hohenegger
Journal:  Biochem J       Date:  2004-07-01       Impact factor: 3.857

Review 8.  Anti-CD38 antibody therapy: windows of opportunity yielded by the functional characteristics of the target molecule.

Authors:  Antonella Chillemi; Gianluca Zaccarello; Valeria Quarona; Manuela Ferracin; Chiara Ghimenti; Massimo Massaia; Alberto L Horenstein; Fabio Malavasi
Journal:  Mol Med       Date:  2013-05-20       Impact factor: 6.354

9.  Correlation of CD38 expression with the progression of hemorrhagic fever with renal syndrome.

Authors:  Han-Dong Zhao; Yan-Ping Li; Wei-Wei Zhao; Peng Li; Hong-Li Liu
Journal:  Arch Virol       Date:  2021-06-10       Impact factor: 2.574

10.  Decreased ADP-ribosyl cyclase activity in peripheral blood mononuclear cells from diabetic patients with nephropathy.

Authors:  Michio Ohtsuji; Kunimasa Yagi; Miyuki Shintaku-Kubota; Yukiko Kojima-Koba; Naoko Ito; Masako Sugihara; Naoto Yamaaki; Daisuke Chujo; Atsushi Nohara; Yoshiyu Takeda; Junji Kobayashi; Masakazu Yamagishi; Haruhiro Higashida
Journal:  Exp Diabetes Res       Date:  2009-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.